Meperidine Hydrochloride Injection Shortage

• • Demerol injection, Pfizer, 100 mg/mL, 20 mL multiple dose vial, 1 count, NDC 00409-1201-20 - discontinued
  • Demerol injection, Pfizer, 50 mg/mL, 2 mL ampule, 25 count, NDC 00409-1255-02

• • Hikma did not provide a reason for the shortage.
  • Pfizer has Demerol injection on shortage due to manufacturing delays. Pfizer discontinued Demerol 50 mg/mL 0.5 mL, 1 mL ampules, and 1.5 mL ampules and 100 mg/mL 1 mL ampules in July 2020. Pfizer discontinued Demerol 100 mg/mL 20 mL vials in April 2021.
  • ICU Medical discontinued meperidine 30 mL PCA vials.

• • Demerol injection, Pfizer, 100 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-1180-69
  • Demerol injection, Pfizer, 25 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-1176-30
  • Demerol injection, Pfizer, 50 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-1178-30
  • Demerol injection, Pfizer, 50 mg/mL, 30 mL multiple dose vial, 1 count, NDC 00409-1181-30
  • Demerol injection, Pfizer, 75 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-1179-30
  • Meperidine injection, Hikma, 100 mg/mL, 1 mL vial, 25 count, NDC 00641-6054-25
  • Meperidine injection, Hikma, 25 mg/mL, 1 mL vial, 25 count, NDC 00641-6052-25
  • Meperidine injection, Hikma, 50 mg/mL, 1 mL vial, 25 count, NDC 00641-6053-25

Estimated Resupply Dates

• • Pfizer has Demerol 50 mg/mL 2 mL ampules on a long-term back order and the company estimates a release date of February 2023.
  • All other marketed presentations are available.